Chemotherapy of leishmaniasis: recent advances in the treatment of visceral disease

Authors
Berman, J
Citation
J. Berman, Chemotherapy of leishmaniasis: recent advances in the treatment of visceral disease, CURR OPIN I, 11(6), 1998, pp. 707-710
Citations number
13
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
CURRENT OPINION IN INFECTIOUS DISEASES
ISSN journal
09517375 → ACNP
Volume
11
Issue
6
Year of publication
1998
Pages
707 - 710
Database
ISI
SICI code
0951-7375(199812)11:6<707:COLRAI>2.0.ZU;2-8
Abstract
New lipid formulations of amphotericin B - AmBisome, Amphotec, and Abelcet - have dramatically decreased the toxicity associated with amphotericin B a nd have made this group of agents the treatment of choice for visceral leis hmaniasis, An agent of a completely different chemical class, the aminoglyc oside aminosidine, was 97% curative in India. This agent too may be used fo r visceral leishmaniasis, Curr Opin Infect Dis 11:707-710. (C) 1998 Lippinc ott Williams & Wilkins.